Effective Reversal of New-Onset Type 1 Diabetes by Treatment with Low Dose Anti-CD3 Monoclonal Antibodies

Home > Archive>Volume , Issue 4, 2008 >47-50

Effective Reversal of New-Onset Type 1 Diabetes by Treatment with Low Dose Anti-CD3 Monoclonal Antibodies
DOI:
                        
                    
CSTR:
                        [cstr]
                    
Author:
                        

Find this author on All Journals
Find this author on BaiDu
Search for this author on this site

                    
Affiliation:
Clc Number:R587.1
Fund Project:

Article

Figures

Metrics

Reference

Cited by

Materials

Comments

Get Citation

Copy

Article Metrics

Abstract:2022
PDF: 0
HTML: 0
Cited by: 0

History

Received:
Revised:
Adopted:
Online:
Published:

Home

About this journal

Editorial Board

Info for Author

Contact Us

中文版

Get Citation

Share

Article Metrics

History

Article QR Code